强脉冲激光联合睑板腺按摩治疗2型糖尿病合并MGD相关干眼的临床效果观察
Clinical Effect of Intense Pulsed Laser Combined with Meibomian Gland Massage in the Treatment of Type 2 Diabetes Mellitus with MGD-Related Dry Eye
DOI: 10.12677/ACM.2023.133703, PDF,    科研立项经费支持
作者: 尹 鑫:青岛大学医学部,山东 青岛;青岛大学附属烟台毓璜顶医院眼科,山东 烟台;李元彬*:青岛大学附属烟台毓璜顶医院眼科,山东 烟台
关键词: 强脉冲激光睑板腺功能障碍干眼2型糖尿病Intense Pulsed Laser Meibomian Gland Dysfunction Dry Eye Type 2 Diabetes Mellitus
摘要: 目的:评价强脉冲激光(IPL)治疗2型糖尿病合并睑板腺功能障碍(MGD)相关干眼的临床效果。方法:前瞻性选取2022.01~2022.10于我院眼科就诊的2型糖尿病合并MGD干眼症患者,根据随机数字表法分为试验组和对照组,试验组采用IPL联合睑板腺按摩治疗,对照组采用睑板腺按摩治疗,每4次治疗为一个疗程。比较两组治疗前及末次治疗后1月、2月的眼表疾病指数量表评分(OSDI)、睑板腺分泌功能评分(MGYSS)、泪河高度(TMH)、首次非侵入性泪膜破裂时间(NIBUTf)、角膜荧光素染色(CFS)。结果:两组患者OSDI、MGYSS、TMH、NIBUTf、CFS基线水平无统计学差异(P > 0.05)。两组治疗后OSDI评分均下降,治疗后2月试验组OSDI评分显著低于对照组(P = 0.015)。两组治疗后MGYSS评分明显上升,治疗后1月、2月,试验组明显高于对照组(P = 0.036; P < 0.001)。治疗后1月、2月,试验组TMH较基线水平改善(P < 0.001; P < 0.001)。两组治疗后NIBUTf都较治疗前升高,治疗后2月试验组NIBUTf明显高于对照组(P = 0.03)。试验组治疗后CFS评分较基线水平明显下降(P < 0.05),治疗后2月,试验组较对照组下降,差异具有统计学意义(P = 0.001)。结论:IPL联合睑板腺按摩治疗能有效减轻2型糖尿病合并MGD相关干眼患者的临床症状,改善睑板腺功能和眼表情况。
Abstract: Objective: To evaluate the clinical effect of intense pulsed light (IPL) in the treatment of type 2 dia-betic mellitus with meibomian gland dysfunction (MGD) related dry eye. Methods: A prospective study was conducted to select patients with type 2 diabetes mellitus and MGD-related dry eye who were treated in ophthalmology department of our hospital from January, 2022 to October, 2022. They were randomly divided into two groups: IPL combined with meibomian gland massage treat-ment group and meibomian gland massage treatment group. Every 4 treatments is a course of treatment. Before treatment and 1 month and 2 months after the last treatment, the ocular surface disease index (OSDI) score, meibomian gland yielding secretion score (MGYSS), tear meniscus height (TMH), first noninvasive tear break-up time (NIBUTf), and corneal fluorescein staining (CFS) were recorded. Results: There were no significant differences in the baseline levels of OSDI, MGYSS, TMH, NIBUTf and CFS between the two groups (P > 0.05). The OSDI scores of the two groups de-creased after treatment, and the OSDI score of the experimental group was significantly lower than that of the control group at 2 months after treatment (P = 0.015). The MGYSS score of the two groups increased significantly after treatment, and in the 1 and 2 months after treatment, the ex-perimental group was significantly higher than the control group (P = 0.036; P < 0.001). In the 1 and 2 months after treatment, TMH in the experimental group was improved compared with the baseline level (P < 0.001; P < 0.001). The NIBUTf of the two groups after treatment was higher than that before treatment, and the NIBUTf of the experimental group was significantly higher than that of the control group at 2 months after treatment (P = 0.03). Compared with the baseline value, the CFS score of the experimental group after treatment significantly decreased (P < 0.05). In the 2 months after treatment, the experimental group decreased compared with the control group (P = 0.001). Conclusion: IPL combined with meibomian gland massage treatment can effectively reduce the clinical symptoms of type 2 diabetes mellitus with MGD-related dry eye patients, improve mei-bomian gland function and ocular surface condition.
文章引用:尹鑫, 李元彬. 强脉冲激光联合睑板腺按摩治疗2型糖尿病合并MGD相关干眼的临床效果观察[J]. 临床医学进展, 2023, 13(3): 4926-4934. https://doi.org/10.12677/ACM.2023.133703

参考文献

[1] Tsubota, K., Pflugfelder, S.C., Liu, Z., et al. (2020) Defining Dry Eye from a Clinical Perspective. International Journal of Molecular Sciences, 21, 9271. [Google Scholar] [CrossRef] [PubMed]
[2] Suwal, A., Hao, J.L., Zhou, D.D., et al. (2020) Use of Intense Pulsed Light to Mitigate Meibomian Gland Dysfunction for Dry Eye Disease. International Journal of Medical Sciences, 17, 1385-1392. [Google Scholar] [CrossRef] [PubMed]
[3] 干眼强脉冲光临床应用专家共识专家组, 中国康复医学会视觉康复专委会干眼康复专业组. 强脉冲光治疗睑板腺功能障碍及其相关干眼专家共识(2022) [J]. 中华实验眼科杂志, 2022, 40(2): 97-103.
[4] Thode, A.R. and Latkany, R.A. (2015) Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD). Drugs, 75, 1177-1185. [Google Scholar] [CrossRef] [PubMed]
[5] 亚洲干眼协会中国分会, 海峡两岸医药交流协会眼科专业委员会眼表与泪液病学组. 我国睑板腺功能障碍诊断与治疗专家共识(2017年) [J]. 中华眼科杂志, 2017, 53(9): 657-661.
[6] Yan, X., Hong, J., Jin, X., et al. (2021) The Efficacy of Intense Pulsed Light Combined with Meibomian Gland Expression for the Treatment of Dry Eye Disease Due to Meibomian Gland Dysfunction: A Multicenter, Ran-domized Controlled Trial. Eye Contact Lens, 47, 45-53. [Google Scholar] [CrossRef
[7] 刘畅, 张琛, 黄悦, 等. 单纯强脉冲光治疗睑板腺功能障碍的疗效观察[J]. 中华实验眼科杂志, 2019, 37(3): 185-189.
[8] Jiang, X., Yuan, H., Zhang, M., et al. (2022) The Efficacy and Safety of New-Generation Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction-Related Dry Eye: A Multicenter, Randomized, Patients-Blind, Parallel-Control, Non-Inferiority Clinical Trial. Ophthalmology and Therapy, 11, 1895-1912. [Google Scholar] [CrossRef] [PubMed]
[9] Toyos, R., Toyos, M., Willcox, J., et al. (2019) Evaluation of the Safety and Efficacy of Intense Pulsed Light Treatment with Meibomian Gland Expression of the Upper Eyelids for Dry Eye Disease. Photobiomodulation, Photomedicine, and Laser Surgery, 37, 527-531. [Google Scholar] [CrossRef] [PubMed]
[10] Yu, T., Han, X.G., Gao, Y., et al. (2019) Morphological and Cyto-logical Changes of Meibomian Glands in Patients with Type 2 Diabetes Mellitus. International Journal of Ophthalmolo-gy, 12, 1415-1419. [Google Scholar] [CrossRef] [PubMed]
[11] Han, S.B., Yang, H.K. and Hyon, J.Y. (2019) Influence of Diabetes Mellitus on Anterior Segment of the Eye. Clinical Interventions in Aging, 14, 53-63. [Google Scholar] [CrossRef
[12] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 检查和诊断(2020年) [J]. 中华眼科杂志, 2020, 56(10): 741-747.
[13] Ozcura, F., Aydin, S. and Helvaci, M.R. (2007) Ocular Surface Disease Index for the Diagnosis of Dry Eye Syndrome. Ocular Immunology and Inflammation, 15, 389-393. [Google Scholar] [CrossRef] [PubMed]
[14] Lane, S.S., Dubiner, H.B., Epstein, R.J., et al. (2012) A New System, the LipiFlow, for the Treatment of Meibomian Gland Dysfunction. Cornea, 31, 396-404. [Google Scholar] [CrossRef
[15] Hassan, A., Balal, S. and Ahmad, S. (2020) Meibomian Gland Dysfunction, Dropout and Distress: Emerging Therapies. Eye (London), 34, 1494-1496. [Google Scholar] [CrossRef] [PubMed]
[16] Siak, J.J., Tong, L., Wong, W.L., et al. (2012) Prevalence and Risk Factors of Meibomian Gland Dysfunction: The Singapore Malay Eye Study. Cornea, 31, 1223-1228. [Google Scholar] [CrossRef
[17] Zou, X., Lu, L., Xu, Y., et al. (2018) Prevalence and Clinical Characteristics of Dry Eye Disease in Community-Based Type 2 Diabetic Patients: The Beixinjing Eye Study. BMC Ophthalmology, 18, 117. [Google Scholar] [CrossRef] [PubMed]
[18] Manaviat, M.R., Rashidi, M., Afkhami-Ardekani, M., et al. (2008) Prevalence of Dry Eye Syndrome and Diabetic Retinopathy in Type 2 Diabetic Patients. BMC Ophthalmology, 8, 10. [Google Scholar] [CrossRef] [PubMed]
[19] Shamsheer, R.P. and Arunachalam, C. (2015) A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes. Middle East African Journal of Ophthalmology, 22, 462-466. [Google Scholar] [CrossRef] [PubMed]
[20] Guo, Y., Zhang, H., Zhao, Z., et al. (2022) Hyperglycemia Induces Meibomian Gland Dysfunction. Investigative Ophthalmology & Visual Science, 63, 30. [Google Scholar] [CrossRef] [PubMed]
[21] Fan, F., Li, X., Li, K., et al. (2021) To Find out the Relationship between Levels of Glycosylated Hemoglobin with Meibomian Gland Dysfunction in Patients with Type 2 Diabetes. Therapeutics and Clinical Risk Management, 17, 797-807. [Google Scholar] [CrossRef
[22] Lin, X., Xu, B., Zheng, Y., et al. (2017) Meibomian Gland Dysfunction in Type 2 Diabetic Patients. Journal of Ophthalmology, 2017, Article ID: 3047867. [Google Scholar] [CrossRef
[23] 邹媛媛, 刘雪梅, 祁媛媛, 等. 糖尿病小鼠睑板腺功能障碍及其炎性因子和脂类代谢因子表达变化[J]. 中华实验眼科杂志, 2022, 40(9): 820-826.
[24] Toyos, R., Mcgill, W. and Briscoe, D. (2015) Intense Pulsed Light Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction: A 3-Year Retrospective Study. Photomedicine and Laser Surgery, 33, 41-46. [Google Scholar] [CrossRef] [PubMed]
[25] Vora, G.K. and Gupta, P.K. (2015) Intense Pulsed Light Therapy for the Treatment of Evaporative Dry Eye Disease. Current Opinion in Ophthalmology, 26, 314-318. [Google Scholar] [CrossRef
[26] Cheng, S.N., Jiang, F.G., Chen, H., et al. (2019) Intense Pulsed Light Therapy for Patients with Meibomian Gland Dysfunction and Ocular Demodex Infestation. Current Medi-cal Science, 39, 800-809. [Google Scholar] [CrossRef] [PubMed]
[27] Yin, Y., Liu, N., Gong, L., et al. (2018) Changes in the Meibo-mian Gland after Exposure to Intense Pulsed Light in Meibomian Gland Dysfunction (MGD) Patients. Current Eye Re-search, 43, 308-313. [Google Scholar] [CrossRef] [PubMed]
[28] Mejía, L.F., Gil, J.C. and Jaramillo, M. (2019) Intense Pulsed Light Therapy: A Promising Complementary Treatment for Dry Eye Disease. Archivos de la Sociedad Española de Oftalmología (English Edition), 94, 331-336. [Google Scholar] [CrossRef] [PubMed]
[29] Shin, K.Y., Lim, D.H., Moon, C.H., et al. (2021) Intense Pulsed Light plus Meibomian Gland Expression versus Intense Pulsed Light Alone for Meibomian Gland Dysfunction: A Ran-domized Crossover Study. PLOS ONE, 16, e0246245. [Google Scholar] [CrossRef] [PubMed]